Found: 3
Select item for more details and to access through your institution.
Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 ( KIR6.2) gene.
- Published in:
- 2006
- By:
- Publication type:
- Letter
No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Infant and toddler type 1 diabetes: complications after 20 years' duration.
- Published in:
- 2012
- By:
- Publication type:
- journal article